ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $755,503 | -12.1% | 68,997 | +6.3% | 0.00% | 0.0% |
| Q2 2023 | $859,381 | +102943.3% | 64,908 | +6.0% | 0.00% | 0.0% |
| Q1 2023 | $834 | -26.6% | 61,247 | +5.2% | 0.00% | -50.0% |
| Q4 2022 | $1,137 | -99.9% | 58,222 | +3.5% | 0.00% | 0.0% |
| Q3 2022 | $1,071,000 | +3.2% | 56,233 | +11.6% | 0.00% | 0.0% |
| Q2 2022 | $1,038,000 | -25.6% | 50,391 | +16.2% | 0.00% | 0.0% |
| Q1 2022 | $1,396,000 | +9.9% | 43,373 | +59.0% | 0.00% | 0.0% |
| Q4 2021 | $1,270,000 | +75.7% | 27,274 | +1.9% | 0.00% | +100.0% |
| Q3 2021 | $723,000 | +7.7% | 26,770 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $671,000 | +5.7% | 26,160 | +40.9% | 0.00% | 0.0% |
| Q1 2021 | $635,000 | +78.4% | 18,566 | +76.4% | 0.00% | – |
| Q4 2020 | $356,000 | +67.1% | 10,527 | +21.7% | 0.00% | – |
| Q3 2020 | $213,000 | – | 8,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |